Accordingly, select ER modulators downregulate VEGF-induced angiogenesis by suppressing HIF-1α/VEGFR2 signaling as well as the activation of AKT and ERK axes in breast cancer cells [185]. This evidence concerns the gene AKT1 and breast cancer.